BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 27022418)

  • 1. DNA Nanotechnology for Cancer Therapy.
    Kumar V; Palazzolo S; Bayda S; Corona G; Toffoli G; Rizzolio F
    Theranostics; 2016; 6(5):710-25. PubMed ID: 27022418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current understanding of biological interactions and processing of DNA origami nanostructures: Role of machine learning and implications in drug delivery.
    Singh M; Sharma D; Garg M; Kumar A; Baliyan A; Rani R; Kumar V
    Biotechnol Adv; 2022 Dec; 61():108052. PubMed ID: 36307050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering DNA self-assemblies as templates for functional nanostructures.
    Wang ZG; Ding B
    Acc Chem Res; 2014 Jun; 47(6):1654-62. PubMed ID: 24588320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA origami as an in vivo drug delivery vehicle for cancer therapy.
    Zhang Q; Jiang Q; Li N; Dai L; Liu Q; Song L; Wang J; Li Y; Tian J; Ding B; Du Y
    ACS Nano; 2014 Jul; 8(7):6633-43. PubMed ID: 24963790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally designed DNA-based nanocarriers.
    Jiang Q; Zhao S; Liu J; Song L; Wang ZG; Ding B
    Adv Drug Deliv Rev; 2019 Jul; 147():2-21. PubMed ID: 30769047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA nanovehicles and the biological barriers.
    Okholm AH; Kjems J
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):183-191. PubMed ID: 27276176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA origami applications in cancer therapy.
    Udomprasert A; Kangsamaksin T
    Cancer Sci; 2017 Aug; 108(8):1535-1543. PubMed ID: 28574639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional DNA nanostructures for photonic and biomedical applications.
    Wang ZG; Song C; Ding B
    Small; 2013 Jul; 9(13):2210-22. PubMed ID: 23733711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA nanostructure-based imaging probes and drug carriers.
    Zhan P; Jiang Q; Wang ZG; Li N; Yu H; Ding B
    ChemMedChem; 2014 Sep; 9(9):2013-20. PubMed ID: 25045126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Creation of DNA Origami-Based Supramolecular Nanostructures for Cancer Therapy.
    Zhang S; Lou XY; Liu L; Yang YW
    Adv Healthc Mater; 2023 Oct; 12(27):e2301066. PubMed ID: 37252899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA nanomaterials for preclinical imaging and drug delivery.
    Jiang D; England CG; Cai W
    J Control Release; 2016 Oct; 239():27-38. PubMed ID: 27527555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Nanotechnology-Enabled Drug Delivery Systems.
    Hu Q; Li H; Wang L; Gu H; Fan C
    Chem Rev; 2019 May; 119(10):6459-6506. PubMed ID: 29465222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress toward Understanding the Interactions between DNA Nanostructures and the Cell.
    Chiu YTE; Li H; Choi CHJ
    Small; 2019 Jun; 15(26):e1805416. PubMed ID: 30786143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Growing Development of DNA Nanostructures for Potential Healthcare-Related Applications.
    Mathur D; Medintz IL
    Adv Healthc Mater; 2019 May; 8(9):e1801546. PubMed ID: 30843670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.
    Frazier N; Ghandehari H
    Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahedral DNA nanostructures as drug delivery and bioimaging platforms in cancer therapy.
    Duangrat R; Udomprasert A; Kangsamaksin T
    Cancer Sci; 2020 Sep; 111(9):3164-3173. PubMed ID: 32589345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA nanotechnology-based development of delivery systems for bioactive compounds.
    Mohri K; Nishikawa M; Takahashi Y; Takakura Y
    Eur J Pharm Sci; 2014 Jul; 58():26-33. PubMed ID: 24694593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine: a new paradigm to overcome drug incompatibilities.
    Abdelkader A; Fathi HA; Hamad MA; Elsabahy M
    J Pharm Pharmacol; 2020 Oct; 72(10):1289-1305. PubMed ID: 32436221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Programming 20-30nm Rectangular DNA Origami for Loading Doxorubicin to Penetrate Ovarian Cancer Cells.
    Li X; Wang X; Li H; Shi X; Zheng P
    IEEE Trans Nanobioscience; 2020 Jan; 19(1):152-157. PubMed ID: 31581088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationally Designed DNA-Origami Nanomaterials for Drug Delivery In Vivo.
    Jiang Q; Liu S; Liu J; Wang ZG; Ding B
    Adv Mater; 2019 Nov; 31(45):e1804785. PubMed ID: 30285296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.